A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: AZD9496 (Reference)|DRUG: AZD9496 Variant A|DRUG: AZD9496 Variant B|DRUG: AZD9496 Variant C|DRUG: AZD9496 Variant D
Sponsor: AstraZeneca
Collaborators: Parexel